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Abstract Accreditation of healthcare services is recom-
mended to ensure operation according to the highest
quality standards. Various initiatives, such as legislation or
accreditation by ISO or JCI, may be active to support and
improve quality. The growing trend toward JCI hospital
accreditation raised the concern of redundancy between
JCI requirements for the use of referral laboratories and the
ISO 15189 accreditation for medical laboratories. This
would result in needless administrative efforts for hospital
laboratories to collect and maintain required documenta-
tion, as the JCI quality requirements would be guaranteed
given that the referral laboratory is ISO 15189 accredited
for those examinations. A consensus meeting was orga-
nized by the Working Group for Hospital Accreditation of
the Belgian Zorgnet-Icuro network, the University Hospi-
tals of Leuven and the Red Cross to discuss the avoidance
of any redundancy between both standards and to issue best
practice guidelines for referral laboratories. It was con-
cluded that JCI measurable elements for referral
laboratories are covered by the ISO 15189 accreditation
scope. The article substantiates the consensus that JCI and
ISO quality requirements are harmonized and that accurate
knowledge and interpretation of prevailing quality stan-
dards are essential to avoid redundancy in quality
measures.
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Introduction
There is an international growing attention for continuous
improvement of the quality of healthcare services [1]. An
established quality management system (QMS) and the
acquirement of accreditation are essential. Efforts are
undertaken by laboratories, hospitals, and governments to
improve quality. More and more hospitals have voluntarily
started moving toward accreditation. Many governments
impose strict quality requirements for medical laboratories.
This article is largely applicable to hospitals and labora-
tories throughout Europe but aims to highlight some
specific issues to reflect on the situation in Belgium.
In Belgium, accreditation requirements differ depending
on the type of laboratory. The quality requirements for
each type are safeguarded under royal decrees of the Bel-
gian Legislation. Centers for human genetics are to be ISO
15189 accredited for 80 % of their activities [2]. For lab-
oratories in anatomopathology, accreditation is not
mandatory, but is a requirement for the reimbursement of
particular molecular oncology tests since 2009 [3]. For
clinical pathology laboratories, accreditation is not
mandatory for the main activities with some exceptions:
national reference laboratories such as AIDS reference
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laboratories, reference laboratories for tropical and infec-
tious diseases, and reference laboratories for microbiology
[4–7]. The molecular tests for microbiology, hematology,
and oncology performed in a clinical pathology laboratory
also fall under a royal decree which requires ISO 15189
accreditation [2].
ISO 15189 is the gold standard for accreditation of
medical laboratories [8]. The ISO 15189 is an international
comprehensive standard for medical laboratories which
covers both Management requirements (Chapter 4) and
Technical requirements (Chapter 5). The laboratory must
fulfill each element and must operate in complete concor-
dance. Each country has its own national accreditation
body (NAB) which is responsible for granting accredita-
tions and which operates according to ISO 17011, the
international standard for accreditation bodies [9].
For hospitals on the other hand, there are no specific
national requirements for accreditation, although over the
last years, hospitals have been increasingly encouraged by
the government to start the journey toward accreditation.
Following international trends, several hospitals have
started international accreditation programs that are cer-
tificated by The International Society for Quality in Health
Care (ISQua). ISQua’s International Accreditation Pro-
gramme (IAP) is a global body that provides a peer review
accreditation framework. The most frequently used hospi-
tal accreditation programs are the NIAZ-QMentum [10]
and the Joint Commission International (JCI) Accreditation
Standards for Hospitals 5th Edition [11].
Even though most hospital laboratories offer a wide
range of tests for patient samples, they may refer a subset
of tests to external laboratories. This may be the case for
rarely performed tests, for specialized analyses or due to
organizational reasons (lack of capacity, infrastructure,
etc.). Of course, the quality of the services provided by
these referral laboratories should be closely monitored by
the referring laboratory or should be guaranteed by the
contract laboratory (e.g., by means of accreditation). Both
JCI and ISO 15189 state specific requirements for the use
of referral laboratories.
JCI uses the term ‘reference laboratory’ and defines this
as ‘‘a laboratory owned and operated by an organization
other than the hospital, with which the hospital contacts for
testing.’’ The requirements for reference laboratories are
listed in the JCI Standards for Hospitals, namely under
Standard AOP.5.10 and AOP.5.10.1 [12]. These intents are
specified in measurable elements (MEs) to indicate the
requirements for full compliance with the standard. MEs
are reviewed and scored during an on-site visit. ISO 15189
uses the term ‘referral laboratory’, which is defined as ‘‘an
external laboratory to which a sample is submitted for
examination. This is a laboratory to which laboratory
management chooses to submit a sample or subsample for
examination or when routine examinations cannot be car-
ried out. This differs from a laboratory that may include
public health, forensics, tumor registry, or a central (parent)
facility to which submission of samples is required by
structure or regulation.’’
Both definitions differ slightly, as the ISO 15189 defi-
nition distinguishes referral laboratories from national
reference laboratories to which samples are sent by struc-
ture or regulation.
Throughout this article, the authors adhere to the ISO
interpretation of a reference laboratory/referral laboratory,
i.e., a laboratory to which samples are sent, other than the
governmentally acknowledged national reference
laboratories.
In the USA, the CAP Laboratory Accreditation Standard
is the golden standard, and therefore, JCI auditors may be
unfamiliar with the full extent of ISO 15189 accreditation
which is much more common in Europe. Hence, the
Working Group is concerned that JCI auditors may not be
aware that ISO 15189 accreditation provides sufficient
evidence for compliance with JCI requirements for the use
of referral laboratories. This would result in requesting
redundant proof of JCI compliance evidence. This redun-
dancy may put unnecessary administrative strain on
hospitals by demanding to collect detailed documentation
from the referral laboratories (e.g., a copy of the license, a
copy of the accreditation certificate, documentation of
EQA participation).
The aim of this article is to clarify which JCI require-
ments are covered if both the referring and referral
laboratories are ISO 15189 accredited. The need for hos-
pitals to establish documentation records of referral
laboratories can be moderated, by supporting that JCI
measurable elements are covered by the ISO 15189
accreditation scope. Its aim is also to issue a best practice
guideline for referral laboratories, to encourage them to
make all necessary information easily accessible for users
of referral laboratory services.
Methods
The initiative was taken by the Working Group for
Hospital Accreditation of the Belgian Zorgnet-Icuro net-
work, the University Hospitals of Leuven and the Red
Cross. Zorgnet-Icuro is a network that groups and repre-
sents healthcare organizations in Flanders. Its goal is to
provide a platform for knowledge exchange and to orga-
nize high-quality health care.
A consensus meeting was organized in March 2015 at
which a total of 21 involved stakeholders were represented:
quality managers of university and regional hospitals, staff
from medical laboratories, scientific organizations, the Red
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Cross, the national accreditation body (BELAC), and the
Scientific Institute for Public Health (WIV-ISP), which
organizes national EQA programs and is responsible for the
licensing of Belgian medical laboratories in clinical
pathology and in pathology [3, 4, 13].
A comparison of JCI measurable elements of the JCI
Accreditation Standard for Hospitals: 5th Edition
(AOP.5.10) and the ISO 15189:2012 Standard for Medical
Laboratories was discussed, and best practice recommen-
dations were issued.
Results and discussion
A comparison of measurable elements of the JCI Accred-
itation Standard for Hospitals: 5th Edition (AOP.5.10) and
the ISO 15189:2012 scope supports that JCI’s MEs for
referral laboratories are covered if the hospital laboratory is
ISO 15189 accredited. Table 1 gives an overview of JCI
requirements and how these are guaranteed when the lab-
oratory is accredited.
ISO 15189 has specific requirements for the use of
referral laboratories. This implies that if the hospital lab-
oratory is accredited, the quality of referral laboratories is
closely monitored as specified in the ISO Standard. The
laboratory director is responsible for the selection of
referral laboratories and for monitoring the quality of their
service (ISO 15189:2012—4.1.1.4). Reference has to be
made to any work referred by the laboratory to a referral
laboratory or consultant (ISO 15189:2012—4.4.1). Fur-
thermore, the laboratory must have a documented
procedure for selecting and evaluating its referral labora-
tories (ISO 15189:2012—4.5). The laboratory is
responsible for monitoring the quality of performance and
for ensuring that referral laboratories are competent to
perform the requested examinations. Arrangements with
referral laboratories are periodically reviewed, and a reg-
ister of all referral laboratories is maintained. Results of all
samples referred are kept for a pre-defined period.
JCI requires that the hospital maintains a copy of the
license (JCI—AOP.5.10 M1) and a copy of the accredita-
tion (JCI—AOP.5.10 M2) for all referral laboratories.
During the consensus meeting, it was suggested that lab-
oratories should ideally make a copy of the license and a
copy of the accreditation certificate (including accredita-
tion scope) available on their website for the users of
laboratory services, or provide a direct link to the official
websites to guarantee easy accessibility.
In Belgium, a frequently updated list of licensed labo-
ratories is available on the website of the national health
insurance organization, RIZIV-INAMI [14]. The list also
categorizes the different types of laboratories: centers for
human genetics (code 996), anatomopathology laboratories
(code 997), and clinical pathology laboratories (code 998).
A list of all accredited laboratories, including the
accreditation scope, can be found on the website of the
national accreditation body BELAC [15]. Since 2006,
BELAC is the only Belgian accreditation organization by
royal decree [16]. BELAC is internationally recognized by
the European co-operation for Accreditation (EA), the
International Laboratory Accreditation Cooperation
(ILAC), and the International Accreditation Forum (IAF).
An overview of the number of accredited laboratories
according to laboratory type is illustrated in Fig. 1. In total,
there are 241 licensed medical laboratories in Belgium.
The greater part of laboratories is situated in Flanders. The
majority of medical laboratories in Belgium are clinical
pathology laboratories. There are only eight centers for
human genetics, which are all ISO 15189 accredited.
Approximately 30 % of the clinical pathology and
pathology laboratories are accredited.
Zorgnet-Icuro, as an umbrella organization for hospitals
in Flanders, collects accreditation data and publishes a list
of hospitals that have started the accreditation pathway on
its website, including the chosen accreditation program and
the survey dates. Table 2 gives an overview of the
accreditation status of hospitals in Flanders. Sixty out of 65
hospitals have chosen for accreditation. One acute hospital
and four revalidation hospitals will not start the accredi-
tation pathway. In December 2015, a total of seven
hospitals had already obtained accreditation, of which five
are accredited by JCI and two by NIAZ. Another 53 hos-
pitals have started the accreditation process.
With regard to transparency of the quality of laborato-
ries, an exemplary initiative is the Orphanet database for
rare diseases. Orphanet offers a worldwide database of
medical laboratories which can be solicited by disease or
gene name, by country, city, laboratory, or by professional.
Interestingly, search results can be filtered by accreditation
status and/or by participation in external quality assurance
(EQA) schemes [17]. This database is recommended to
retrieve information about accreditation and EQA partici-
pation of laboratories performing tests in the field of rare
diseases.
According to JCI, the hospital must document that the
referral laboratory participates in proficiency testing pro-
grams (JCI—AOP.5.10 M3). However, this requirement is
automatically fulfilled if the referral laboratory is ISO
15189 accredited for those examinations. Indeed, accredi-
tation implies that the laboratory participates in external
quality assessment programs (5.6.3). Moreover, in Bel-
gium, participation in EQA programs is mandatory for
licensing by royal decree, apart from accreditation
[2–4, 18]. This means that even non-accredited laboratories
have to participate in the EQA programs offered by the
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The hospital maintains a copy of the license,
from a recognized licensing authority, for
all reference laboratories used by the
hospital
Outcome of consensus meeting: Copy should
be made available from the laboratory’s
website, or a direct link to a published
governmental list should be foreseen
Laboratory should provide a link to a copy of
the license on its website, or a list should




The hospital maintains a copy of the
certificate or letter of accreditation or
certification, from a recognized laboratory
accreditation or certification program, for
all reference laboratories used by the
hospital
Outcome of consensus meeting: copy
(including the scope) should be made
available from the laboratory’s website or
a direct link to a published list by the NAB
should be foreseen
Laboratory should provide a link to a copy of
the accreditation or to the NAB’s website,
where all accredited laboratories are listed,
including the accreditation scope
AOP.5.10
M3
The hospital maintains documentation that
any reference laboratory used by the




If a laboratory is accredited and the test is
included in the accreditation scope, the




The frequency and type of performance
expectation data from reference
laboratories are determined by the hospital
ISO 15189:2012—4.2.2.2: Quality Manual
ISO 15189:2012—5.4.2.d, 5.4.2.h, 5.4.2.j:
Information for patients and users
ISO 15189:2012—4.14.7: Quality indicators
The quality policy, QMS, and organizations
structure are included in the Quality
Manual
Information on the examinations offered are
made available for users of the laboratory
services: This includes required samples,
sample volumes, special precautions,
turnaround time, biological reference
intervals, and clinical decision values.
Instructions for sample transportation and
the laboratory’s criteria for accepting and
rejecting samples are communicated
Quality indicators to monitor performance
throughout critical aspects of pre-
examination, examination and post-
examination processes are established.
The process of monitoring quality
indicators is planned and periodically
reviewed. Turn-around times for all




The qualified individual responsible for the
laboratory or a qualified designee reviews
the performance expectation data from
reference laboratories
ISO 15189:2012—4.15: Management review
ISO 15189:2012—4.5.1a through 4.5.1.d:
Selecting and evaluating referral laboratories
and consultants
The management review assesses the QMS at
planned intervals and includes a large
scope of evaluation types. The laboratory
is responsible for selecting referral
laboratories and consultants, and for
monitoring their competence and quality.
Arrangements are periodically evaluated,
and records of reviews and referral




The responsible individual or qualified
designee takes action based on the results
ISO 15189:2012—4.15: Management review
ISO 15189:2012—4.1.1.4.i: Laboratory
director
Causes of nonconformities and process
problems are analyzed
Opportunities for improvement and the need
for changes to the QMS are assessed
Actions arising from management review are
completed within a defined timeframe
The laboratory director has the necessary
competence and is responsible for
selecting referral laboratories and
monitoring the quality of their services
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Scientific Institute for Public Health (WIV-ISP) to main-
tain their license and to obtain reimbursement for medical
tests.
Due to the ISO 15189 requirements for the Quality
Manual, for the availability of information for users of
laboratory services, and for the establishment of quality
indicators (ISO 15189:2012—4.2.2.2 and 5.4.2.d, 5.4.2.h,
5.4.2.j, and 4.14.7), the frequency and type of performance
expectation data of the referral laboratory can be monitored
(JCI—AOP.5.10.1 M1).
As specified in the ISO Standard, information available
for the users of laboratory services includes the types of
clinical services offered (including examinations referred
to other laboratories), information concerning the exam-
inations offered (samples required, sample volumes,
precautions, turnaround time, etc.), instructions for com-
pletion of the request form, instructions for preparation of
the patient, instructions for transportation of samples,
requirements for patient consent, criteria for accepting
and rejecting samples, a list of factors known to affect the
examination or the result interpretation, etc. The labora-
tory establishes quality indicators to monitor and evaluate
performance throughout critical aspects of pre-examina-
tion, examination, and post-examination processes (e.g.,
number of unacceptable samples, number of registration
errors, etc.).
Quality indicators are evaluated by a planned process
(establishing objectives, methodology, interpretation, lim-
its, action plan, and duration of measurement) and are
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Fig. 1 a Distribution of the types of medical laboratories in Belgium (n = 241). b Overview of the number of accredited laboratories in Belgium
according to laboratory type
Table 2 Overview of the accreditation status of hospitals in Flanders
Accreditation status Number of
hospitals
(n = 65)
JCI accredited 5 (8 %)
NIAZ accredited 2 (3 %)
JCI accreditation pathway started 18 (27 %)
NIAZ accreditation started 30 (46 %)
Accreditation started but no details which standard 5 (8 %)










An annual report of the data from reference
laboratories is provided to hospital
leadership to facilitate management of
contracts and contract renewals
ISO 15189:2012—4.15: Management review
ISO 15189:2012—4.5.1.c: Selecting and
evaluating referral laboratories and
consultants
The interval between management reviews is
not greater than 12 months, and findings
from management reviews are recorded
and reported to laboratory staff.
Arrangements with referral laboratories
and consultants are evaluated periodically,
and records of periodic reviews are
maintained
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Turnaround times that reflect clinical needs are established
and subject to periodic evaluation.
The quality control policy, the scope of the quality
management system, the management structure, the roles
and responsibilities of laboratory management, and the
structure of documentation are extensively elaborated in
the Quality Manual.
Moreover, the JCI International Patient Safety Goals
require defining critical values for each type of diagnostic
test and a process for reporting critical results (IPSG.2.1).
ISO 15189 requires a review of the quality management
system (ISO 15189:2012—4.15) at planned intervals (no
greater than 12 months) to ensure its suitability, adequacy
and effectiveness, and support of patient care. A large
scope of evaluation results are included in this management
review (user feedback, internal audits, quality indicators,
performance of suppliers, results of external quality
assessment participation, risk management, etc.). This
information is analyzed for causes of nonconformities and
patterns that indicate process problems. Opportunities for
improvement and the need for changes to the quality
management system are assessed, and actions arising from
management review are completed within a defined time-
frame. These actions cover the JCI requirements stated
under AOP.5.10.1 M2, M3, and M4.
Moreover, the competence and quality of the selected
referral laboratories and consultants are monitored, peri-
odically evaluated, and a register of all referral services is
maintained (ISO 15189:2012—4.5.1a through 4.5.1.d). The
laboratory director is a person with the necessary compe-
tences and is responsible for selecting referral laboratories
and for monitoring the quality of their services (ISO
15189:2012—4.1.1.4.i). These ISO 15189 requirements
assure the periodic review of performance expectation data
by a qualified designee (AOP.5.10.1 M2, M3 and M4).
Conclusion and recommendations for referral
laboratories
ISO 15189 accreditation provides evidence for continued
assurance of high-quality services for the tests included in
the accreditation scope. This quality assurance by ISO
15189 accreditation, in addition to the documentation of
licensing by the Belgian authorities, fully meets the JCI
requirements concerning referral laboratories, at least for
tests included in the referral laboratory’s accreditation
scope.
Recommendations toward laboratories include:
1. For licensed and accredited laboratories, it is unneces-
sary to arrange Service Level Agreements (SLA)
between the hospital and the referral laboratory. In case
the hospital prefers to establish SLAs with their referral
laboratories, this can be limited to the requirement that
the referral laboratory is licensed and ISO 15189
accredited for the referred tests.
Gathering documentation such as a copy of the license,
a copy of the accreditation certificate, copies of EQA
results etc., is unnecessary. Licensing and accreditation
evidence are available at the BELAC website and at the
website of the national health insurance organization,
RIZIV-INAMI, and can be made available on the
referral laboratory’s website. EQA results of the referral
laboratory do not need to be requested as ISO 15189
accreditation guarantees surveillance of test quality,
EQA participation, as well as communication of any
corrective and preventive actions.
2. It is strongly advised for each laboratory to make the
following information available on its website:
• An overview of the tests that are performed, including
• Test frequency and sample flow
• Turn-around times
• Pre-analytical requirements (sampling require-
ments and transport to the laboratory)
• Particular specifications of the analysis
• Whether or not the test is included in the accred-
itation scope (if yes, this implies EQA participation
for the particular disease/parameter)
• Lists of specialists and contact details of the
laboratory
• Link toward the license (governmental organization)
and/or link to a copy of the license with the
registration number
• Link to the website of the national accreditation body,
where the accreditation status and the accreditation
scope can be found.
From the discussion at the consensus meeting, the
ascertainment deemed that quality systems and other
quality requirements, whether stated by ISO or JCI Stan-
dard or by legislation, should support each other and should
serve the same purpose. This has been proven for Belgium,
where the international ISO 15189, the JCI Standard for
Hospital Accreditation and the Belgian legislation are
harmonized and are asking for highly comparable quality
requirements.
However, excessive administrative pressure should be
avoided by not demanding redundancy in documentation
and service agreements. This article proves that JCI and
ISO quality requirements are harmonized and that accu-
rate knowledge and interpretation of prevailing quality
standards is essential to avoid redundancy in quality
measures.
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